Canurta Journal

On December 7, 2024, Canurta Therapeutics participated in the 35th International Symposium on ALS/MND, hosted by the Motor Neurone...

A 2016 study explored the potential of cannabinoids as therapeutic agents for Amyotrophic Lateral Sclerosis (ALS), focusing on their...

A study investigated the optimal germination period for maximizing the production of cannflavin A (CFL-A) and cannflavin B (CFL-B) in...

A retrospective cohort study assessed the effectiveness of medical marijuana (MM) in managing symptoms and progression of Amyotrophic...

Heart disease is a growing problem in the global population. One of the contributing factors, cardiac hypertrophy, can lead to severe...

Recent research has illuminated the intricate relationship between the gut microbiota and brain function, known as the gut-brain axis....

Research conducted by the University of Alberta and Canurta collaborators dives into how cannflavin-C, a natural compound derived from...

The landscape of cannabis pharmacology, once predominantly focused on tetrahydrocannabinol (THC), has dramatically expanded since the...

Recent scientific investigations have uncovered the significant cytoprotective effects of cannflavins A and B, two flavonoids derived...

Recent explorations into the bioactive compounds of Cannabis sativa have identified three cannflavins with potential efficacy against...

In recent research, the spotlight turns to flavonoids, potent natural compounds found in fruits and vegetables, revealing their...

Research has unveiled the potential of cannflavin A, a novel flavonoid derived from cannabis, as a promising agent in the fight against...

We are pleased to present our research poster detailing our preclinical study on a first-in-class ALS therapy formulation. This work was...

This week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...

Recent scientific advancements have cast a spotlight on Cannabis sativa, not just as a source of major cannabinoids like THC and CBD,...

The Cannabis plant, historically recognized for its diverse applications from textiles to therapeutics, continues to unveil its molecular...

Synthetic biology is revolutionizing the way we produce plant flavonoids, compounds known for their health-promoting properties. By...

This article was originally published on March 2, 2023 by The College of Biological Science at the University of Guelph:...

Advancing Research of Understudies Second Metabolite Compounds University of Alberta researchers, backed by Canurta, have gained new...

Setting the Benchmark for Precision and Credibility in Botanical Drug Development Canurta proudly introduces a transformative development...